These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32611266)

  • 1. Molecular docking and statistical optimization of taurocholate-stabilized galactose anchored bilosomes for the enhancement of sofosbuvir absorption and hepatic relative targeting efficiency.
    Joseph Naguib M; Moustafa Kamel A; Thabet Negmeldin A; Elshafeey AH; Elsayed I
    Drug Deliv; 2020 Dec; 27(1):996-1009. PubMed ID: 32611266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes.
    Mohsen AM; Asfour MH; Salama AAA
    Drug Dev Ind Pharm; 2017 Dec; 43(12):2043-2054. PubMed ID: 28756693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Readily restoring freeze-dried probilosomes as potential nanocarriers for enhancing oral delivery of cyclosporine A.
    Guan P; Lu Y; Qi J; Wu W
    Colloids Surf B Biointerfaces; 2016 Aug; 144():143-151. PubMed ID: 27085046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galactose decorated PLGA nanoparticles for hepatic delivery of acyclovir.
    Gupta S; Agarwal A; Gupta NK; Saraogi G; Agrawal H; Agrawal GP
    Drug Dev Ind Pharm; 2013 Dec; 39(12):1866-73. PubMed ID: 22397550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam.
    Al-Mahallawi AM; Abdelbary AA; Aburahma MH
    Int J Pharm; 2015 May; 485(1-2):329-40. PubMed ID: 25796122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical optimization of bile salt deployed nanovesicles as a potential platform for oral delivery of piperine: accentuated antiviral and anti-inflammatory activity in MERS-CoV challenged mice.
    Zakaria MY; Fayad E; Althobaiti F; Zaki I; Abu Almaaty AH
    Drug Deliv; 2021 Dec; 28(1):1150-1165. PubMed ID: 34121561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of bilosomes as nanocarriers for transdermal delivery of tizanidine hydrochloride: in vitro and ex vivo optimization.
    Khalil RM; Abdelbary A; Kocova El-Arini S; Basha M; El-Hashemy HA
    J Liposome Res; 2019 Jun; 29(2):171-182. PubMed ID: 30221568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eprosartan mesylate loaded bilosomes as potential nano-carriers against diabetic nephropathy in streptozotocin-induced diabetic rats.
    Ahad A; Raish M; Ahmad A; Al-Jenoobi FI; Al-Mohizea AM
    Eur J Pharm Sci; 2018 Jan; 111():409-417. PubMed ID: 29030177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved oral delivery of resveratrol using proliposomal formulation: investigation of various factors contributing to prolonged absorption of unmetabolized resveratrol.
    Basavaraj S; Betageri GV
    Expert Opin Drug Deliv; 2014 Apr; 11(4):493-503. PubMed ID: 24456117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes).
    Shukla A; Khatri K; Gupta PN; Goyal AK; Mehta A; Vyas SP
    J Pharm Pharm Sci; 2008; 11(1):59-66. PubMed ID: 18445364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facilitated permeation of insulin across TR146 cells by cholic acid derivatives-modified elastic bilosomes.
    Bashyal S; Seo JE; Keum T; Noh G; Choi YW; Lee S
    Int J Nanomedicine; 2018; 13():5173-5186. PubMed ID: 30233179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and
    El-Nabarawi MA; Shamma RN; Farouk F; Nasralla SM
    J Liposome Res; 2020 Mar; 30(1):1-11. PubMed ID: 31010357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes.
    Shukla A; Katare OP; Singh B; Vyas SP
    Int J Pharm; 2010 Jan; 385(1-2):47-52. PubMed ID: 19835938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous Optimization of Oral and Transdermal Nanovesicles for Bioavailability Enhancement of Ivabradine Hydrochloride.
    Naguib MJ; Elsayed I; Teaima MH
    Int J Nanomedicine; 2021; 16():2917-2931. PubMed ID: 33911861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Novel Bilosomal System for Improved Oral Bioavailability of Sertraline Hydrochloride: Formulation Design, In Vitro Characterization, and Ex Vivo and In Vivo Studies.
    Ismail A; Teiama M; Magdy B; Sakran W
    AAPS PharmSciTech; 2022 Jul; 23(6):188. PubMed ID: 35799076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming the Bile Salt-Mediated Formation of Nanocolloids That Inhibit Oral Absorption of VX-985.
    Song B; Bransford P; Peresypkin A; Medek A; Mudunuri P; Randles EG; Dworakowski W; Kumar S; Snyder PW
    J Pharm Sci; 2019 Feb; 108(2):821-831. PubMed ID: 30385281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galactosylated Chitosan Coated Liposomes of Ledipasvir for Liver Targeting: Chemical Synthesis, Statistical Optimization, In-vitro and In-vivo evaluation.
    Fatouh AM; Elshafeey AH; Abdelbary A
    J Pharm Sci; 2021 Mar; 110(3):1148-1159. PubMed ID: 33039437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chrysin loaded bilosomes improve the hepatoprotective effects of chrysin against CCl4 induced hepatotoxicity in mice.
    Naseri A; Taymouri S; Hosseini Sharifabadi A; Varshosaz J
    J Biomater Appl; 2023 Oct; 38(4):509-526. PubMed ID: 37632164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach.
    Kharouba M; El-Kamel A; Mehanna R; Thabet E; Heikal L
    Drug Deliv; 2022 Dec; 29(1):2925-2944. PubMed ID: 36081339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anionic versus cationic bilosomes as oral nanocarriers for enhanced delivery of the hydrophilic drug risedronate.
    Elnaggar YSR; Omran S; Hazzah HA; Abdallah OY
    Int J Pharm; 2019 Jun; 564():410-425. PubMed ID: 31029657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.